28 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
2-Alkoxy-3-(sulfonylarylaminomethylene)-chroman-4-ones as potent and selective inhibitors of ectonucleotidases.
Forman Christian College (A Chartered University)
Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors.
Comsats Institute of Information Technology
Discovery and optimization of betulinic acid derivatives as novel potent CD73 inhibitors.
The Second Military Medical University
Structure-Activity Relationship of 3-Methylcytidine-5'-?,?-methylenediphosphates as CD73 Inhibitors.
National Institute of Diabetes and Digestive and Kidney Diseases
Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors.
Arcus Biosciences
Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production.
Oric Pharmaceuticals
Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor.
Ningxia Medical University
Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39.
Arcus Biosciences
Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73.
Arcus Biosciences
2-Substituted ?,?-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes.
University of Bonn
Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors.
National Institute of Diabetes and Digestive and Kidney Diseases
Lead optimization and biological evaluation of fragment-based cN-II inhibitors.
Universit£
CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates.
Universit£
Inhibitors of CD73 May Provide a Treatment for Cancer and Autoimmune Diseases.
Therachem Research Medilab (India)
